Literature DB >> 7252157

Selective desensitization of neutrophils: further studies with 1-O-alkyl-sn-glycero-3-phosphocholine analogues.

J T O'Flaherty, C J Lees, C H Miller, C E McCall, J C Lewis, S H Love, R L Wykle.   

Abstract

Human polymorphonuclear neutrophils aggregate and degranulate in response to 2 recently described platelet-activating phospholipids: 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine and 1-O-alkyl-2-O-ethyl-sn-glycero-3-phosphocholine. Here, we find that the 2 phospholipids can also desensitize neutrophils. Thus, cells incubated with either phosphocholine for 1 to 5 min in the absence of calcium and magnesium (which are required for aggregation) did not aggregate when exposed to the bivalent cations and fresh lipid stimulus. Also, cells incubated with either lipid for 5 min in the absence of cytochalasin B (which is required for degranulation) did not degranulate when exposed to cytochalasin B and fresh lipid stimulus. However, these desensitized neutrophils aggregated and degranulated fully in response to the chemotactic oligopeptide N-formyl-methionyl-leucylphenylalanine and C5a. In relation to the aggregation response, this selective desensitization was not due to lipid inactivation; it persisted after thorough cell washing; and it was not induced by a nonaggregating analogue, 1-O-alkyl-sn-glycerol-3-phosphocholine. Furthermore, cells desensitized to the formylated oligopeptide or C5a (by preincubation with either stimulus in the absence of bivalent cations) did not aggregate when challenged with the oligopeptide or C5a, respectively, but exhibited a normal or enhanced aggregation response to the 2 active phospholipids. These data support the concept that C5a, formylated oligopeptides, and phosphocholines represent 3 distinct classes of stimulants that activate and densensitize neutrophils by at least partially independent pathways. This activation and desensitization may be mediated by 3 types of cellular receptors, each of which interacts with only 1 class of stimuli.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7252157

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  Correlation of desensitisation of platelet activating factor (PAF) receptors with intensity of inflammation and intestinal PAF content during experimental ileitis in guinea pig.

Authors:  O Jeanneton; M Delvaux; Y Langlois; P Le Bars; J Le Bars; M B Delisle; J Frexinos; L Bueno
Journal:  Gut       Date:  1998-09       Impact factor: 23.059

2.  Desensitization of calcium mobilization and cell function in human neutrophils.

Authors:  G H Lee; J S Kaptein; S J Scott; H Niedzin; C I Kalunta; P M Lad
Journal:  Biochem J       Date:  1989-08-15       Impact factor: 3.857

3.  Synergistic platelet activation by aggregates of IgG and the phospholipid platelet-activating factor 1-O-alkyl-2-acetyl-SN-glycero-3-phosphorylcholine.

Authors:  F H Valone
Journal:  J Clin Immunol       Date:  1986-01       Impact factor: 8.317

4.  Effect of a PAF antagonist, BN52063, on PAF-induced bronchoconstriction in normal subjects.

Authors:  N M Roberts; M McCusker; K F Chung; P J Barnes
Journal:  Br J Clin Pharmacol       Date:  1988-07       Impact factor: 4.335

Review 5.  Biology and biochemistry of platelet-activating factor.

Authors:  J T O'Flaherty; R L Wykle
Journal:  Clin Rev Allergy       Date:  1983-09

6.  Isolation of a platelet membrane protein which binds the platelet-activating factor 1-0-hexadecyl-2-acetyl-SN-glycero-3-phosphorylcholine.

Authors:  F H Valone
Journal:  Immunology       Date:  1984-05       Impact factor: 7.397

7.  Regulation of platelet-activating-factor receptors and the desensitization response in polymorphonuclear neutrophils.

Authors:  J T O'Flaherty; D P Jacobson; J F Redman
Journal:  Biochem J       Date:  1992-11-15       Impact factor: 3.857

8.  Endotoxin-induced selective dysfunction of rabbit polymorphonuclear leukocytes in response to endogenous chemotactic factors.

Authors:  K T Hartiala; L Langlois; I M Goldstein; J T Rosenbaum
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

9.  Enhancement of human polymorphonuclear leukocyte adherence by the phospholipid mediator 1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphorylcholine (AGEPC).

Authors:  F H Valone; E J Goetzl
Journal:  Am J Pathol       Date:  1983-10       Impact factor: 4.307

10.  Specific binding by human polymorphonuclear leucocytes of the immunological mediator 1-O-hexadecyl/octadecyl-2-acetyl-sn-glycero-3-phosphorylcholine.

Authors:  F H Valone; E J Goetzl
Journal:  Immunology       Date:  1983-01       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.